Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents

Clinical Endocrinology

Volumn 55, Issue 5, 2001, Pages 617-624

  Fors, Hans ^a   Bjarnason, Ragnar ^a   Wirén, Lena ^a   Albertsson Wikland, Kerstin ^a   Bosaeus, Ingvar ^a   Bengtsson, Bengt Åke ^b   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; GLUCOCORTICOID; GROWTH HORMONE; LEVOTHYROXINE; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MASS; BONE MINERALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMUR NECK; GROWTH HORMONE DEFICIENCY; HEIGHT; HORMONAL THERAPY; HORMONE RELEASE; HUMAN; MALE; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; SHORT STATURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BODY HEIGHT; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR NECK; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; LUMBAR VERTEBRAE; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES;

EID: 0035724479     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01386.x     Document Type: Article

References (36)

1. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
2. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
3. Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency
4. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism
5. Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency
6. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence
7. Le pic de masse osseuse: Realites et incertitudes
8. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency
9. Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men
10. Metabolic effects of discontinuing growth hormone treatment
11. Consequences of childhood-onset growth hormone deficiency for adult bone mass
12. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo-controlled study with open follow-up
13. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement
14. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: A placebo controlled study
15. The bone-remodelling transient: Implications for the interpretation of clinical studies of bone mass change
16. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women
17. Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
18. Growth hormone therapy and fracture risk in the growth hormone-deficient adult
19. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
20. I. Physical growth from birth to 16 years and longitudinal outcome of the study during the same age period
21. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
22. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency
23. Extended effects on bone of 3 years growth hormone treatment in postmenopausal osteoporosis
24. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: A double blind, placebo-controlled study
25. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model
26. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency
27. Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: An interim report
28. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy
29. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass
30. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency
31. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults
32. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency
33. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
34. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: A two-year placebo-controlled study
35. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults
36. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males